AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,406,000 | -15.5% | 1,670,000 | 0.0% | 0.21% | -9.6% |
| Q4 2021 | $13,494,000 | -39.5% | 1,670,000 | -26.6% | 0.23% | -34.3% |
| Q3 2021 | $22,295,000 | -24.1% | 2,275,000 | -47.9% | 0.35% | -31.5% |
| Q2 2021 | $29,376,000 | -25.6% | 4,365,000 | 0.0% | 0.51% | -25.0% |
| Q1 2021 | $39,460,000 | +35.3% | 4,365,000 | 0.0% | 0.68% | +35.7% |
| Q4 2020 | $29,158,000 | +37.7% | 4,365,000 | +3.9% | 0.50% | +66.8% |
| Q3 2020 | $21,168,000 | -42.6% | 4,200,000 | -8.0% | 0.30% | -58.7% |
| Q2 2020 | $36,890,000 | +6.4% | 4,565,655 | +4.6% | 0.73% | -37.7% |
| Q1 2020 | $34,663,000 | – | 4,365,655 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |